# Spectral CT Combined With MSI for Predicting Regional Lymph Node Metastasis in Gastric Cancer

> **NCT07565818** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Yunnan Cancer Hospital** · enrollment: 260 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DIAGNOSTIC_TEST:** o explore the value of spectral CT in the diagnosis and treatment of gastric cancer with different MSI statuses

## Key facts

- **NCT ID:** NCT07565818
- **Lead sponsor:** Yunnan Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-04
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07565818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07565818, "Spectral CT Combined With MSI for Predicting Regional Lymph Node Metastasis in Gastric Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07565818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*